Advertisement
Home Tags Cancer: Prostate

Tag: Cancer: Prostate

Men with localized prostate cancer benefit from radical prostatectomy

Radical Prostatectomy Has Lasting Benefit for Localized Cancer

Mean 2.9 years gained after 23 years of follow-up among men with localized prostate cancer
Men with inflammatory bowel disease have an increased risk for prostate cancer

Inflammatory Bowel Disease, Prostate Cancer Linked

At age 60, men with inflammatory bowel disease have higher values of prostate-specific antigen
The combination of visual registration and image fusion should be used when targeted biopsy is being performed on men with suspected prostate cancer

Visual Registration + Image Fusion Best for Targeted Biopsy

Combination of the strategies identifies the most clinically important prostate cancers
For patients with prostate cancer

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

Heart failure risk higher for androgen deprivation therapy users in propensity score-matched analysis
A lack of understanding of terminology

Barriers to Prostate Cancer Research in Black Men Identified

Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation

The American Society for Radiation Oncology, Oct. 21-24

The 60th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology...
A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy

Hypofractionated Radiation OK for Localized Prostate CA

New multidisciplinary guideline for early-stage prostate cancer developed by three professional societies
For men with low- and intermediate-risk prostate cancer

ASTRO: Long-Term Benefit for Stereotactic Radn in Prostate CA

Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer
Midlife levels of prostate-specific antigen strongly predict future development of aggressive prostate cancer among black men

Midlife PSA Predicts Aggressive Prostate Cancer in Black Men

Findings suggest potential for a targeted screening approach based on midlife PSA
Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging

Guideline-Discordant Prostate Cancer Imaging Up With Medicare

Patients in VA and Medicare group, VA-only group less likely to receive guideline-discordant imaging